+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Throat Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Throat Cancer Therapeutics Market 2024-2028

  • Report
  • December 2023
  • 158 Pages
  • Global
From
Gallbladder Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Gallbladder Cancer Therapeutics Market 2024-2028

  • Report
  • December 2023
  • 166 Pages
  • Global
From
Phosphoinositide 3-Kinase (PI3K) Inhibitors Market 2024-2028 - Product Thumbnail Image

Phosphoinositide 3-Kinase (PI3K) Inhibitors Market 2024-2028

  • Report
  • December 2023
  • 163 Pages
  • Global
From
Anaplastic Thyroid Cancer Drugs Market 2024-2028 - Product Thumbnail Image

Anaplastic Thyroid Cancer Drugs Market 2024-2028

  • Report
  • December 2023
  • 151 Pages
  • Global
From
Mycosis Fungoides Therapeutics Market 2021-2025 - Product Thumbnail Image

Mycosis Fungoides Therapeutics Market 2021-2025

  • Report
  • February 2021
  • 120 Pages
  • Global
From
From
Checkpoint Kinase 2 (Chk2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Checkpoint Kinase 2 (Chk2) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Casein Kinase 2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Casein Kinase 2 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Superoxide Dismutase (SOD) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Superoxide Dismutase (SOD) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Cathepsin K/S Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cathepsin K/S Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cathepsin K Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cathepsin K Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more